| 2026-03-13 | UPC_CFI_722/2025 | Milan CD | Revocation Action | Nichtigkeit (Hauptsache) | outcomeName.other | The Milan Central Division ordered disposal of Neurocrine Biosciences' revocation action (R. 360 RoP) against EP 3 784 233 because the patent had been definitively and entirely revoked by the EPO Opposition Division, rendering the revocation action devoid of purpose. Neurocrine's conditional request (disposal only if Spruce undertook not to enforce divisional patents) was held outside R. 360 RoP. Spruce (claimant/respondent) was ordered to pay 80% of maximum recoverable costs (EUR 488,000) to Neurocrine; Neurocrine was reimbursed 60% of court fees (EUR 12,000). |
| 2025-12-19 | UPC_CFI_681/2024 | Munich LD | Counterclaim for revocation | Nichtigkeit (Hauptsache) | Nicht verletzt | The Munich Local Division dismissed both the infringement action (UPC_CFI_437/2024) brought by GXD-Bio Corporation and the counterclaim for revocation (UPC_CFI_681/2024) brought by the Myriad defendants, concerning EP 3 346 403 (a patent on data processing/gene expression analysis for identifying endogenous reference genes). The Court found no infringement because the accused products (Myriad test kits) did not use the claimed three-step normalization method — the products used a single-step average normalization that differed from the patented calculation method. The counterclaim for revocation was also dismissed, so the patent was maintained. Each party bears its own costs, with costs capped at EUR 600,000 total. |
| 2025-10-23 | UPC_CFI_497/2024 | Milan CD | Revocation Action | Nichtigkeit (Hauptsache) | Patent geändert | The Central Division Milan rejected the revocation action by bioMérieux against Labrador Diagnostics' EP 3 756 767 B1 (diagnostic test patent), maintaining the patent in amended form pursuant to Auxiliary Request 3; bioMérieux was ordered to pay EUR 400,000 in legal costs to Labrador. |
| 2025-07-18 | CC_54050/2024 | Milan CD | Counterclaim for revocation | Prozessual | Nur prozessual | The Milan Central Division issued a procedural order following an interim conference in this counterclaim for revocation, setting the schedule and framework for the oral hearing and managing witness declarations. |
| 2025-07-18 | ACT_48305/2024 | Milan CD | Revocation Action | Prozessual | Nur prozessual | Procedural order issued after the interim conference of 14 July 2025 in a revocation/counterclaim for revocation action concerning EP 3 756 767. The order sets out case management decisions including the oral hearing schedule, treatment of declarants, submission deadlines, and requests parties to agree on the value of the action. |